We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.7B
AUM Growth
+$144M
Cap. Flow
+$80.4M
Cap. Flow %
1.2%
Top 10 Hldgs %
21%
Holding
1,675
New
169
Increased
710
Reduced
579
Closed
127

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Financials 10.66%
3 Industrials 8.29%
4 Consumer Discretionary 7.5%
5 Healthcare 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FYC icon
1126
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.24B
$419K 0.01%
+5,409
New +$425K
FSLR icon
1127
First Solar
FSLR
$21.4B
$418K 0.01%
2,372
-781
-25% -$155K
WTFC icon
1128
Wintrust Financial
WTFC
$10.7B
$417K 0.01%
3,341
-502
-13% -$62K
NTRS icon
1129
Northern Trust
NTRS
$21.8B
$416K 0.01%
4,063
-1,691
-29% -$173K
COHR icon
1130
Coherent
COHR
$43.4B
$416K 0.01%
4,396
-1,941
-31% -$194K
LIT icon
1131
Global X Lithium & Battery Tech ETF
LIT
$1.46B
$416K 0.01%
10,210
-491
-5% -$21.6K
ADX icon
1132
Adams Diversified Equity Fund
ADX
$3.01B
$416K 0.01%
20,599
+248
+1% +$5.29K
CDW icon
1133
CDW
CDW
$18.9B
$416K 0.01%
2,389
+701
+42% +$136K
SLGN icon
1134
Silgan Holdings
SLGN
$4.51B
$415K 0.01%
7,980
P
1135
Everpure Inc
P
$23B
$415K 0.01%
+6,757
New +$376K
NRK icon
1136
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
$415K 0.01%
39,679
+2,289
+6% +$24.9K
MRNA icon
1137
Moderna
MRNA
$21.6B
$414K 0.01%
9,964
-27,823
-74% -$1.33M
IYG icon
1138
iShares US Financial Services ETF
IYG
$2.13B
$412K 0.01%
5,298
+5
+0.1% +$386
VONG icon
1139
Vanguard Russell 1000 Growth ETF
VONG
$41.2B
$411K 0.01%
3,980
+243
+7% +$24.6K
DFUV icon
1140
Dimensional US Marketwide Value ETF
DFUV
$15.3B
$410K 0.01%
10,028
EMB icon
1141
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$409K 0.01%
4,594
-853
-16% -$77.9K
PD icon
1142
PagerDuty
PD
$830M
$407K 0.01%
22,305
-3,345
-13% -$64.1K
FLXR
1143
TCW Flexible Income ETF
FLXR
$3.45B
$407K 0.01%
+10,526
New +$410K
FSCO
1144
FS Credit Opportunities Corp
FSCO
$999M
$407K 0.01%
59,685
+11,480
+24% +$76.2K
HCI icon
1145
HCI Group
HCI
$2.34B
$405K 0.01%
3,476
+23
+0.7% +$2.62K
FDUS icon
1146
Fidus Investment
FDUS
$759M
$405K 0.01%
19,269
+3,560
+23% +$72.1K
REGL icon
1147
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.77B
$404K 0.01%
5,010
+53
+1% +$4.42K
MMYT icon
1148
MakeMyTrip
MMYT
$5.38B
$404K 0.01%
3,597
-2,215
-38% -$237K
ALNY icon
1149
Alnylam Pharmaceuticals
ALNY
$38.3B
$404K 0.01%
1,716
-190
-10% -$50K
PNW icon
1150
Pinnacle West Capital
PNW
$12.4B
$404K 0.01%
4,761
-299
-6% -$26.6K

Similar funds

Oppenheimer & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Oppenheimer & Co held 1,675 positions worth $6.7B, up 2.2% from $6.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q4 2024 filing shows 169 new, 710 increased, 579 reduced and 127 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M. The largest sale was FT Vest US Equity Deep Buffer ETF March, an estimated $21.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q4 2024 buy was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M.
  • Oppenheimer & Co added most to iShares Russell Mid-Cap Growth ETF in Q4 2024, an estimated $12.8M increase.
  • Oppenheimer & Co's biggest Q4 2024 reduction was FT Vest US Equity Deep Buffer ETF March, cutting an estimated $21.8M.
  • Oppenheimer & Co fully exited Innovative Industrial Properties in Q4 2024, selling an estimated $6.32M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.7B portfolio in Q4 2024.
  • Oppenheimer & Co opened 169 new positions and closed 127 in Q4 2024.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $6.7B.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.